A collaborative study has uncovered microproteins exclusive to liver tumors, presenting a new avenue for cancer vaccine development. These microproteins…
Read More »Cancer
Dr. Jan Böttcher, group leader and TUM Junior Fellow at the Institute of Molecular Immunology at Klinikum rechts der Isar…
Read More »
In a major genetic study, over 5,000 variants linked to increased cancer risk were identified in the BAP1 gene, revealing…
Read More »
Developed by MIT researchers, Leuko’s device offers a noninvasive method for cancer patients to monitor their immune health at home.…
Read More »
A breakthrough treatment uses nutrient-based nanomedicine to reactivate dormant metabolic pathways in cancer cells, effectively stopping melanoma growth. This new…
Read More »
Research at Georgia State University focusing on Ethiopian medicinal plants is showing potential in combating cervical cancer. Led by Professor…
Read More »
Fibrolamellar carcinoma (FLC), a rare liver cancer in young people, is caused by a gene fusion due to a chromosome…
Read More »
UCLA researchers have enhanced immunotherapy for malignant gliomas by combining a dendritic cell vaccine with poly-ICLC, showing promising improvements in…
Read More »
By St. Jude Children’s Research Hospital June 18, 2024 Researchers have discovered that T cells can outlast the organism they…
Read More »
Recent research highlights the critical impact of air pollution on cardiovascular disease in cancer patients, exacerbating health conditions and mortality…
Read More »